BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36509540)

  • 1. [Application value of neutrophil lymphocyte ratio combined with age in the diagnosis of dual-phenotype hepatocellular carcinoma].
    Wang KD; Lu GY; Diao XP; Wang L; Zhou PC; Ma F; Fan XJ
    Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(46):3686-3692. PubMed ID: 36509540
    [No Abstract]   [Full Text] [Related]  

  • 2. A multivariate model based on gadoxetic acid-enhanced MRI using Li-RADS v2018 and other imaging features for preoperative prediction of dual‑phenotype hepatocellular carcinoma.
    Liu MT; Zhang JY; Xu L; Qu Q; Lu MT; Jiang JF; Zhao XC; Zhang XQ; Zhang T
    Radiol Med; 2023 Nov; 128(11):1333-1346. PubMed ID: 37740839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative Diagnosis of Dual-Phenotype Hepatocellular Carcinoma Using Enhanced MRI Radiomics Models.
    Wu Q; Yu YX; Zhang T; Zhu WJ; Fan YF; Wang XM; Hu CH
    J Magn Reson Imaging; 2023 Apr; 57(4):1185-1196. PubMed ID: 36190656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
    Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
    [No Abstract]   [Full Text] [Related]  

  • 5. [The prediction value of enhanced magnetic resonance imaging nomogram model for dual phenotype hepatocellular carcinoma].
    Wu Q; Yu YX; Fan YF; Hu S; Yao FR; Wang XM; Hu CH
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(15):1086-1092. PubMed ID: 35436807
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic Value of MRI Features in Dual-phenotype Hepatocellular Carcinoma: A Preliminary Study.
    Gu HX; Huang XS; Xu JX; Zhu P; Xu JF; Fan SF
    J Digit Imaging; 2023 Dec; 36(6):2554-2566. PubMed ID: 37578576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-phenotype hepatocellular carcinoma: correlation of MRI features with other primary hepatocellular carcinoma and differential diagnosis.
    Zhang L; Chen J; Lai X; Zhang X; Xu J
    Front Oncol; 2023; 13():1253873. PubMed ID: 38273849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
    Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H
    Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics for diagnosis of dual-phenotype hepatocellular carcinoma using Gd-EOB-DTPA-enhanced MRI and patient prognosis.
    Huang X; Long L; Wei J; Li Y; Xia Y; Zuo P; Chai X
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):2995-3003. PubMed ID: 31664520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictive value of neutrophil to lymphocyte ratio on 28-day mortality of patients with severe pneumonia].
    Liang H; Gao Y; Miao C; Song Y; He F
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Jul; 31(7):827-831. PubMed ID: 31441404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior.
    Lu XY; Xi T; Lau WY; Dong H; Zhu Z; Shen F; Wu MC; Cong WM
    Ann Surg Oncol; 2011 Aug; 18(8):2210-7. PubMed ID: 21308485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prognostic Role of a Combined Fibrinogen and Neutrophil-to-Lymphocyte Ratio Score in Patients with Resectable Hepatocellular Carcinoma: A Retrospective Study.
    Kong W; Xu H; Cheng J; Fang Z; Wang H; Zhang J; Wang X; Dai T; Gao Y
    Med Sci Monit; 2020 Jan; 26():e918824. PubMed ID: 31929496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological Features and Post-resection Prognosis of Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.
    Jung DH; Hwang S; Kim KH; Hong SM; Lee YJ; Ahn CS; Moon DB; Ha TY; Song GW; Park GC; Yu ES; Lee SG
    World J Surg; 2017 Mar; 41(3):825-834. PubMed ID: 27812807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dynamic monitoring of the neutrophil/lymphocyte ratio could predict the prognosis of patients with bloodstream infection].
    Yang M; Li L; Su N; Lin J; Wang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Jun; 27(6):471-6. PubMed ID: 26049186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma.
    Hu J; Wang N; Yang Y; Ma L; Han R; Zhang W; Yan C; Zheng Y; Wang X
    BMC Gastroenterol; 2018 Dec; 18(1):186. PubMed ID: 30545306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and Prognostic Value of Neutrophil-Lymphocyte Ratio in Adrenocortical Carcinoma.
    Ma C; Yang B; Mao Q
    Clin Genitourin Cancer; 2024 Apr; 22(2):109-114. PubMed ID: 37852864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment of risk evaluation model of peritoneal metastasis in gastric cancer and its predictive value].
    Zhao J; Zhou R; Zhang Q; Shu P; Li H; Wang X; Shen Z; Liu F; Chen W; Qin J; Sun Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):47-52. PubMed ID: 28105619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
    Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
    World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
    Xiao GQ; Yang JY; Yan LN
    Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):588-95. PubMed ID: 26663006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
    Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.